BioSpace News Archive

Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™.

ChromaCode, Inc., a next generation molecular diagnostic company using data science to significantly enhance multiplexing capabilities on existing life science instrumentation, today announced that it will host a corporate workshop and present multiple posters during the upcoming Clinical Virology Symposium

Shane Nho, M.D., M.S., Midwest Orthopaedics at Rush, to present on HipCheck and HipMap, innovative tools designed to deliver procedural efficiency, facilitate patient education and improve patient-specific results

Incyte Corporation announced that it will present at the following investor conferences during the month of May

Dicerna™ Pharmaceuticals, Inc. (Nasdaq:DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the submission of an updated investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for DCR-PHXC, the Company’s lead GalXC™ product candidate for the treatment of all forms of primary hyperoxaluria (PH).

Centene Corporation (NYSE: CNC) announced today it will present at two healthcare conferences in May.

Heska Corporation (NASDAQ: HSKA) (News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, announced that members of Heska’s executive team will be presenting at the following upcoming conferences in May 2019:

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that the Company will host a conference call on Thursday, May 9, 2019

More than 175 Advocates Take Action Together in the Nation’s Capital to END EPILEPSY®

Alliance for Better Health senior leader will help group develop a standardized terminology set for expansion of ICD-10 Z codes